Nengquan Sheng

513 citations
17 papers · 366 indexed · h-index 9
Topics
Colorectal Cancer Surgical Treatments (5 papers)RNA Research and Splicing (4 papers)Colorectal Cancer Treatments and Studies (3 papers)
Partner nations
China

In The Last Decade

Nengquan Sheng

17 papers receiving 363 citations

Peers

Nengquan Sheng
Comparison fields: 5 of 59
  • Molecular Biology 251
  • Cancer Research 143
  • Oncology 94
  • Pulmonary and Respiratory Medicine 53
  • Biomedical Engineering 37
Replace Yuanjun Hu with:
Yuanjun Hu China
Zhenrong Tang China
Siriporn Proungvitaya Thailand
Peter W. Nagle Netherlands
Zirui He China
Richard Gunu United Kingdom
Wenbo Zheng China
Siwei Ju China
Blaž Grošelj Slovenia
Zhixiang Zhuang China
Nengquan Sheng relative to Yuanjun Hu China Yuanjun Hu's profile →
Citations per field
00.5×1.5×1.8×
Yuanjun Hu · 1×
Citations per year

Countries citing papers authored by Nengquan Sheng

Since Specialization
Citations

This map shows the geographic impact of Nengquan Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nengquan Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nengquan Sheng more than expected).

Fields of papers citing papers by Nengquan Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nengquan Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nengquan Sheng. The network helps show where Nengquan Sheng may publish in the future.

Co-authorship network of co-authors of Nengquan Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Nengquan Sheng. A scholar is included among the top collaborators of Nengquan Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nengquan Sheng. Nengquan Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 1
2 8
3 8
4 1
5 7
6 2
7 6
8 3
9 63
10 28
11 22
12 66
13 36
14 28
15 64
16 20
17
Targeted treatment of liver metastasis from gastric cancer using specific binding peptide.
3

About Nengquan Sheng

Nengquan Sheng is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 17 papers that have together received 366 indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (5 papers), RNA Research and Splicing (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Cancer Research (143 citations), Molecular Biology (251 citations) and Oncology (94 citations). Nengquan Sheng has collaborated with scholars based in China. Frequent co-authors include Weiqiang You, Gewen Tan, Zhigang Wang, Hongqi Chen, Jianfeng Gong, Yan Li, Landian Hu, Zhigang Wang, Di Chen and Huizhen Zhang. Their work appears in journals such as Small, Nanoscale and Biosensors and Bioelectronics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026